New York Office of Cannabis Management and Montefiore Einstein Open Registration for …
#77 Strong Clinical Relevance
High-quality evidence with meaningful patient or clinical significance.
The New York Office of Cannabis Management and Montefiore Einstein have opened registration for a two-day symposium focusing on cannabinoids in clinical practice and research. Topics are anticipated to cover evidence-based clinical applications and emerging research, with potential implications for clinicians managing patients using cannabis-based treatments.
🔬 A new symposium, co-hosted by the New York Office of Cannabis Management and Montefiore Einstein, focuses on “Cannabinoids in Clinical Practice and Research.” This event promises to delve into evidence-based clinical applications and emerging research in the field. While the complexity of cannabis as a therapeutic agent is well-known, with numerous potential benefits and risks, it’s crucial for healthcare providers to stay informed about the latest findings. As the legal landscape continues to evolve, understanding the role of cannabinoids in clinical practice can help providers make more informed decisions when discussing treatment options with patients. This symposium could provide valuable insights that may ultimately improve patient care in the realm of cannabis-related therapies.
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
